Etilevodopa

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Etilevodopa
Etilevodopa.svg
Ball-and-stick model of the etilevodopa molecule
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ECHA InfoCard100.223.003 Edit this at Wikidata
Chemical and physical data
FormulaC11H15NO4
Molar mass225.241 g/mol g·mol−1
3D model (JSmol)
  (verify)

Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.

See also[edit]

References[edit]

  1. ^ Djaldetti Ruth; Giladi Nir; Hassin-Baer Sharon; Shabtai Hertzel; Melamed Eldad (November–December 2003). "Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study". Clinical Neuropharmacology. 26 (6): 322–326. doi:10.1097/00002826-200311000-00012. PMID 14646613.